CO4290297A1 - Derivados del indol que tienen actividad inhibidora de este- roide 5 alfa-reductasas - Google Patents

Derivados del indol que tienen actividad inhibidora de este- roide 5 alfa-reductasas

Info

Publication number
CO4290297A1
CO4290297A1 CO94036078A CO94036078A CO4290297A1 CO 4290297 A1 CO4290297 A1 CO 4290297A1 CO 94036078 A CO94036078 A CO 94036078A CO 94036078 A CO94036078 A CO 94036078A CO 4290297 A1 CO4290297 A1 CO 4290297A1
Authority
CO
Colombia
Prior art keywords
reductasas
roide
este
alfa
inhibiting activity
Prior art date
Application number
CO94036078A
Other languages
English (en)
Inventor
Julian Blagg
Graham Nigel Maw
David James Rawson
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of CO4290297A1 publication Critical patent/CO4290297A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/307—Compounds having groups having acetal carbon atoms bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/313—Compounds having groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/784—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic with all keto groups bound to a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LOS COMPUESTSO DE FORMULA (I): FIGURA 1 Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, DONDE R ES CO2R12 Y R12 ES H O UN GRUPO QUE FORMA UN ESTER BIOLABIL O R ES TETRAZOL-5-ILO Y, BIEN (a) R1 ES FIGURA 2 Y R2 ES F, Cl, Br, I, CH3 O CF3, O (b) R1 ES ALQUILO DE C3-C6 Y R2 ES ALQUILO DE C2- C4, SON INHIBIDORES SELECTIVOS DE 5 ALFA-REDUCTASA -1.
CO94036078A 1993-08-17 1994-08-16 Derivados del indol que tienen actividad inhibidora de este- roide 5 alfa-reductasas CO4290297A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939317096A GB9317096D0 (en) 1993-08-17 1993-08-17 Indoles

Publications (1)

Publication Number Publication Date
CO4290297A1 true CO4290297A1 (es) 1996-04-17

Family

ID=10740625

Family Applications (1)

Application Number Title Priority Date Filing Date
CO94036078A CO4290297A1 (es) 1993-08-17 1994-08-16 Derivados del indol que tienen actividad inhibidora de este- roide 5 alfa-reductasas

Country Status (18)

Country Link
US (1) US5912357A (es)
EP (1) EP0714390B1 (es)
JP (1) JP2833865B2 (es)
AT (1) ATE188695T1 (es)
AU (1) AU7497794A (es)
CA (1) CA2167397C (es)
CO (1) CO4290297A1 (es)
DE (1) DE69422629T2 (es)
DK (1) DK0714390T3 (es)
EC (1) ECSP941143A (es)
ES (1) ES2140552T3 (es)
FI (1) FI960730A0 (es)
GB (1) GB9317096D0 (es)
GR (1) GR3032845T3 (es)
IL (1) IL110627A0 (es)
PE (1) PE16695A1 (es)
PT (1) PT714390E (es)
WO (1) WO1995005375A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
FR2796279B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
GB9115951D0 (en) * 1991-07-24 1991-09-11 Pfizer Ltd Indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles

Also Published As

Publication number Publication date
GR3032845T3 (en) 2000-07-31
EP0714390A1 (en) 1996-06-05
DE69422629T2 (de) 2000-06-29
GB9317096D0 (en) 1993-09-29
ES2140552T3 (es) 2000-03-01
WO1995005375A1 (en) 1995-02-23
FI960730A (fi) 1996-02-16
JPH09500142A (ja) 1997-01-07
JP2833865B2 (ja) 1998-12-09
DE69422629D1 (en) 2000-02-17
DK0714390T3 (da) 2000-05-01
CA2167397C (en) 2000-12-12
IL110627A0 (en) 1994-11-11
ATE188695T1 (de) 2000-01-15
US5912357A (en) 1999-06-15
FI960730A0 (fi) 1996-02-16
CA2167397A1 (en) 1995-02-23
AU7497794A (en) 1995-03-14
PT714390E (pt) 2000-06-30
ECSP941143A (es) 1995-01-16
PE16695A1 (es) 1995-06-21
EP0714390B1 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
NO923745L (no) Nye 2-substituerte indan-2-carboxyalkylderivater anvendbare som inhibitorer av enkefalinase og ace
ES2192588T3 (es) 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas.
NO923744L (no) Nye 2-substituerte indan-2-mercaptoacetylamidderivater anvendbare som inhibitorer av enkefalinase og ace
CO4920242A1 (es) Compuestos inhibidores de metalopreoteasas 1,4-heterocicli- cos, composiciones farmaceuticas que los contienen y metodos para su utilizacion
ATE206420T1 (de) Methylenoxindolderivate und verfahren zu ihrer herstellung
ES2092316T3 (es) Agentes antianginosos de purinona.
ES2179823T3 (es) Inmunosupresor macrolido.
UY25987A1 (es) Procedimiento para preparar complejo del inhibidor de ras-fa rnesiltransferasa y sulfobutileter-7-beta-ciclodextrina o 2- hidroxipropil-beta-ciclodextrina y método
AR006360A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
ES2167931T3 (es) Derivados bifenilicos sustituidos por un radical aromatico o heteroaromatico y composiciones farmaceuticas y cosmeticas que los contienen.
DK0618193T3 (da) Nitrogenholdige, bicycliske derivater som prolyl-endopeptidaseinhibitorer
CO4290297A1 (es) Derivados del indol que tienen actividad inhibidora de este- roide 5 alfa-reductasas
MX9306529A (es) Derivados de pirazol condensado, metodo para fabricarlos y composicion farmaceutica que los contiene
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
ES2182090T3 (es) Nuevos derivados de pirrol.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
CO4750819A1 (es) Procedimientos para inhibir el inhibidor del activador del plasminogeno 1
UY26568A1 (es) Nuevos derivados de amidas heterocíclicas
AR025610A1 (es) Derivados de triazol que tienen actividad antifungal
ID26946A (id) Senyawa-senyawa baru
NO178334C (no) Nye 2-merkaptomethylen-tetrahydronafthalen- og indan-2-carboxamidderivater som enkefalinaseinhibitorer
ECSP930947A (es) Sales de cefalosporina y procedimiento para su preparacion
ECSP014089A (es) Derivados de tropano utiles en terapia
IT1271703B (it) "derivati 6-o 7-sostituiti del 4-aminoandrostadienone e procedimento per la loro preparazione"
ECSP972009A (es) Procedimientos para inhibir tumores de colon